Featured Trial

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Study Identifier:

SEP361-226

ClinicalTrials.gov Identifier:

EudraCT Identifier:

N/A

Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborator:

N/A

Study Contact Information:

Recruiting

Type

Interventional

Phase

Phase 2/Phase 3

Estimated Enrollment

434

Trial Dates

Mar 2023 - Feb 2026

Study Drug

Drug: SEP-363856

Drug: Placebo

Therapeutic Area

Anxiety

Trial Locations

No locations found.